MARKET

PODD

PODD

Insulet Corp
NASDAQ
154.16
-6.24
-3.89%
After Hours: 159.08 +4.92 +3.19% 19:59 05/08 EDT
OPEN
161.55
PREV CLOSE
160.40
HIGH
164.66
LOW
154.00
VOLUME
1.74M
TURNOVER
--
52 WEEK HIGH
354.88
52 WEEK LOW
148.31
MARKET CAP
10.68B
P/E (TTM)
35.88
1D
5D
1M
3M
1Y
5Y
1D
Moat Strategies Join Tech-Led April Rebound
Seeking Alpha · 10h ago
Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus
Seeking Alpha · 13h ago
Most healthcare companies report higher Y/Y EPS in strong earnings week
Seeking Alpha · 1d ago
Insulet (PODD) Is Down 6.8% After Raising 2026 Guidance And Advancing Closed‑Loop Trial - What's Changed
Simply Wall St · 1d ago
Why Is SPDR S&P 500 ETF Trust (SPY) Up Today, 5/8/2026?
TipRanks · 2d ago
Insulet Is Maintained at Underweight by Barclays
Dow Jones · 2d ago
Insulet Price Target Cut to $198.00/Share From $286.00 by Barclays
Dow Jones · 2d ago
Barclays Maintains Underweight on Insulet, Lowers Price Target to $198
Benzinga · 2d ago
More
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Webull offers Insulet Corp stock information, including NASDAQ: PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.